Form D — Vinci Pharmaceuticals, Inc.
0001785495-26-000003 · filed Jan 26, 2026
Offering amounts describe securities offered; amounts sold are issuer-reported as of each filing. Amendments can repeat earlier amounts. We do not add these figures into a capital-raised total. Missing amounts are not zero. Data coverage and methodology · How to interpret the amounts.
Check this disclosure on SEC EDGAR · More Other Health Care filings
Offering
- Industry
- Other Health Care
- Exemptions
- 06b
- Reported offering amount
- $25,348,339
- Reported amount sold
- $20,218,331
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Vinci Pharmaceuticals, Inc.
- CIK
- 1785495
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- —
- Address
- 12 Washington Avenue
Avon by the Sea, NJ 07717 - Phone
- 914-582-8305
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Philip Gioia · Executive OfficerAvon by the Sea, NJ Find on LinkedIn ↗
-
Sarah Hassan · DirectorAvon by the Sea, NJ Find on LinkedIn ↗
-
Sigurd Kirk · DirectorAvon by the Sea, NJ Find on LinkedIn ↗
-
Richard Lindstrom · DirectorAvon by the Sea, NJ Find on LinkedIn ↗
-
Neil Austrian Jr. · DirectorAvon by the Sea, NJ Find on LinkedIn ↗
View the original filing on SEC EDGAR ↗